American health regulator USFDA has filed a motion in a
"No legal proceeding has been initiated against us and we continue to co-operate with the department of justice," a company spokesperson told a news agency.
The spokesperson, however, admitted that USFDA had filed a motion in a
The spokesperson refused to disclose as to what the USFDA was seeking clarifications on from the company.
A section of the media has reported that USFDA has taken Ranbaxy to the court for systematic fraudulent conduct and has asked the court to force Ranbaxy to internally review the manufacturing operations.
The spokesperson said Ranbaxy will remain committed to supply high quality generic medicine at affordable prices the to US customers , the spokesperson added.
Sunday, July 13, 2008
US FDA moves to court against Ranbaxy
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment